The company’s fourth-quarter results were highlighted as a testament to the brand’s health and customer appeal. Telsey noted that the year-end earnings reflect a well-received product lineup and brand loyalty, despite the conservative fiscal year 2024 guidance provided by Bath & Body Works.
Telsey raises Bath & Body Works shares target to $53 on strong Q4
